Broncus Holding Corp

Broncus Holding Corporation is a medical device company focused on the development and commercialization of interventional pulmonology devices in China and internationally. Its product portfolio includes InterVapor for COPD, the BroncAblate Radiofrequency Ablation System for lung cancer, the BroncTarget Targeted Lung Denervation Radiofrequency Ablation System for acute COPD exacerbation management, H-Marker for marking lung nodules during surgery, Mist Fountain for airway anesthesia and drug delivery, and BroncTru, a transbronchoscopic dilatation catheter. The company also offers navigation products such as LungPoint Virtual Bronchoscopic Navigation, LungPoint Plus/Archimedes Lite, and the LungPro System, as well as diagnostic products including FleXNeedle, Archimedes Sheath, Archimedes Dilation Balloon, BioStarNeedle, and Steerable Sheath. Incorporated in 2012, Broncus Holding is headquartered in Hangzhou, China.